Bml-210

• Background :

  A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 µM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.

• Description :

  HDAC inhibitor

• Product Name Alternative :

  N1- (2-aminophenyl) -N8-phenyloctanediamide

• UNSPSC :

  41116105

• Type :

  Inhibitor

• Source :

  Synthetic

• Field of Research :

  Cell Signaling | Epigenetics and Nuclear Signaling | Cancer

• Purity :

  >98% (TLC), NMR conforms

• Weight :

  0.025

• Format :

  Tan Solid

• Solubility :

  Soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol

• Molecular Formula :

  C20H25N3O2

• Molecular Weight :

  339.4

• Precautions :

  Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• References & Citations :

  1. Savickiene J., et al. (2006) Eur. J. Pharmacol. 549: 9. 2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.

• CAS Number :

  537034-17-6